Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Nontoxic compounds for the treatment and prevention of herpesvirus infections

Therapeutic Compositions Comprising Mesenchymal Stem Cell Particles And Related Methods

SPATIOTEMPORAL REGULATORS

Methods and compositions for selecting siRNA of improved functionality

Methods of treating a wound using epigenetic regulation

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Modulation of micrornas against myotonic dystrophy type 1 and antagonists of micrornas therefor

COMPOSITIONS AND METHODS FOR TARGETING FRUCTOSE ENZYMES AND TRANSPORTERS FOR THE TREATMENT OF CANCER

Method of determining target nucleic acid

Treatment for glaucoma and other eye diseases

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS

Exosomes and miRNA to treat glaucoma

Let-7 microRNA and mimetics thereof as therapeutics for cancer

HIV pre-immunization and immunotherapy

Therapeutic compositions and methods of making and using the same

Pharmaceutical composition for treating cancer comprising microrna as active ingredient

Pharmaceutical composition for treating and/or preventing cancer

COMPOSITIONS COMPRISING CURONS AND USES THEREOF

Short hairpin RNA compositions, methods of making and applications thereof

RAAV-based compositions and methods

Quantitative ligandomics for systematic identification of therapeutic ligands

HIV pre-immunization and immunotherapy

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

MicroRNA-198 as a tumor suppressor in ovarian cancer

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)

Generation of cancer stem cells and use thereof

PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery

INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING

Lipid-derived neutral nanoparticles

Micro-RNA Delivery Compositions, Devices, and Methods

THERAPEUTICALLY MODULATING APOB AND APOAI

EXOSOME SECRETION INHIBITOR

Algal lipid productivity via genetic modification of a TPR domain containing protein

MiR-127 agents for use in the treatment of renal fibrosis

METHOD OF REGULATING GENE EXPRESSION

Genomic sequences encoding for an attenuated mutant Zika virus

Compositions comprising reversibly modified oligonucleotides and uses thereof

Methods for treating subjects suffering from acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles

Compositions of Ascorbic Acid and Bone Morphogenetic Protein 4 (BMP-4) for Cell Growth and Uses Related Thereto

Use of MIR101 or MIR128 in the treatment of seizure disorders

Modulatory polynucleotides

MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE- ASSOCIATED MEDICAL CONDITIONS

Exosome-based therapeutics against neurodegenerative disorders

Compositions and methods for treating Huntington's disease

MIR-149-3P AND METHOD FOR TREATING METABOLIC DISEASE USING THE SAME

Targeting MicroRNAs for Metabolic Disorders

Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)

MicroRNA Compounds and Methods for Modulating MIR-122

Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases

RNAi induced huntingtin gene suppression

Compositions and methods for modulating neuronal excitability and motor behavior

T cell differentiation and function regulation by decreasing let7 expression

Methods to prevent or treat periodontitis or peri-implantitis

Compositions and methods for selective inhibition of grainyhead-like protein expression

Modified U6 promoter system for tissue specific expression

Compositions and methods for manipulation of adipocyte energy consumption regulatory pathway

Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor

MIR-29 MIMICS AND USES THEREOF

Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases

miRNA for treatment of breast cancer

NOVEL NON-CODING RNA, CANCER TARGET AND COMPOUNDS FOR CANCER TREATMENT

MicroRNA-143 derivative

Inhibitors of metastasis

MATRIX BOUND NANOVESICLES AND THEIR USE

Compositions and methods for delivery of agents

Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy

KIT OR DEVICE FOR DETECTING MALIGNANT BRAIN TUMOR AND METHOD FOR DETECTING SAME

Modulation of adipose tissue macrophage phenotype by use of MicroRNA-30

Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors

Construction of MicroRNA gene-mediated novel tissue engineered nerve and applications thereof in repairing nerve defect

CYTOCOMPATIBLE HYDROGELS FOR ENCAPSULATION OF CELLS

Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies

Methods and compositions for treating atherosclerosis

Medicament for liver regeneration and for treatment of liver failure

BIOMARKERS AND TREATMENTS FOR HEART FAILURE

AAV vectors for treatment of dominant retinitis pigmentosa

Exosome packaging of nucleic acids

MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

In-vitro induction of adult stem cell expansion and derivation

miRNAs USEFUL FOR IDENTIFYING TARGETS ASSOCIATED WITH CANCER

Bacteria-Mediated Gene Modulation Via microRNA Machinery

Recombinant AAVS having useful transcytosis properties

DOWNREGULATING MIR-132 FOR THE TREATMENT OF LIPID RELATED DISORDERS

Therapeutic strategies for ovarian cancer: AMHR2-RNA aptamer

Therapeutic for treatment of diseases including the central nervous system

Methods and compositions for the activation of gamma-delta T-cells

5-halouracil-modified microRNAs and their use in the treatment of cancer

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

MicroRNA composition for the treatment of neuroblastoma

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Compositions and methods of using piRNAS in cancer diagnostics and therapeutics

Method and System for the Diagnosis, Prevention or Treatment of Alzheimer s and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development

Adeno-associated virus vector delivery of microRNA-29 and micro-dystrophin to treat muscular dystrophy

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy

Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions

Targeting pleiotrophin signaling to limit high-grade glioma invasion

MIRNA PROFILING COMPOSITIONS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization

Method of producing cells resistant to HIV infection

Pharmaceutical composition for treating and/or preventing cancer

MICRO-RNA PROFILING, COMPOSITIONS, AND METHODS OF TREATING DISEASES

Gene vector

Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats

Methods and compositions for inhibiting detoxification response

Oligonucleotides

Engineered immunostimulatory bacterial strains and uses thereof

Methods for modulating Ataxin 2 expression

Engineered microbial population

Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)

Micrornas and uses thereof

Regulation of mesodermal specification

MiRNA biomarkers for cartilage degeneration

Peptides and nanoparticles for intracellular delivery of molecules

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

Formulation comprising extracellular vesicles, method for producing the same, and uses thereof

Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions

Methods and compositions for reprogramming cells

Pharmaceutical composition for treating and/or preventing cancer

THERAPEUTIC AND DIAGNOSTIC MOLECULES

EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Micro-RNAs as biomarkers for subconcussive and concussive injury and therapeutic applications

Methods and compositions for reprogramming cells

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

Direct reprogramming of cells to cardiac myocyte fate

Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration

Delivery method of target material into extracellular vesicles using extracorporeal shockwave

Supplementation of milk formulas with microvesicles isolated from milk

Oncolytic viral vectors and uses thereof

THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS

Compositions for use in recovering or ameliorating deterioration of physiological functions due to aging

METHODS OF CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE

Composition for preventing or treating keloid or hypertrophic scars

Argonaute protein-double stranded RNA complexes and uses related thereto

Natural type miRNA for controlling gene expression, and use of same

Toxic RNAi active seed sequences for killing cancer cells

AGE-RELATED MACULAR DEGENERATION TREATMENT

Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER FIBROSIS

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES

Method for treating schizophrenia

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

SAMHD1 MODULATION FOR TREATING RESISTANCE TO CANCER THERAPY

MODULATION OF MICRORNA 184 TO TREAT PATHOLOGICAL LYMPHANGIOGENESIS

Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof

Methods and compositions relating to proteasome inhibitor resistance

Methods and compositions for the activation of gamma-delta T-cells

Nucleic acid molecules containing spacers and methods of use thereof

Transgenic plant of the species with resistance to

MicroRNA Compounds and Methods for Modulating MIR-21 Activity

Targeting MicroRNAs for the Treatment of Fibrosis

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

Method and System for Monitoring Nutritional Uptake as a Function of Hydrogen Gas Levels

Modified AAV constructs and uses thereof

Extracellular vesicles with enhanced potency

HIV pre-immunization and immunotherapy

INHIBITORS OF MICRORNAs miR-155, miR-103, miR-105 and miR-107 THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

Bioactive renal cells

Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier

LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS

Biodegradable lipids for delivery of nucleic acids

Biodegradable lipids for delivery of nucleic acids

Biodegradable lipids for delivery of nucleic acids

Biodegradable lipids for delivery of nucleic acids

Viral vectors for the treatment of diabetes

NUCLEIC ACID MOLECULES WITH ENHANCED ACTIVITY

RAAV-BASED COMPOSITIONS AND METHODS

METHODS AND COMPOSITIONS FOR THE TREATMENT OF A METABOLIC DISORDER

Compositions and methods for modulating FMR1 expression

Compositions and methods for treating HIV-associated neurocognitive disorders

Methods for therapeutic administration of messenger ribonucleic acid drugs

Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds

METHODS AND KITS FOR DETECTNG ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Recombinant vectors comprising 2A peptide

Use of trinucleotide repeat RNAs to treat cancer

MODIFIED POLY (BETA-AMINO ESTER)S FOR DRUG DELIVERY

Methods for detection of RNase activity

Methods and compositions to treat liver diseases and conditions

Nanoparticle conjugates and uses thereof

Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates

Hybrid tRNA/pre-miRNA molecules and methods of use

Compositions and methods of using anti-mullerian hormone for treatment of infertility

Methods and Materials for Producing Fruit of Altered Size

Structurally-enhanced miRNA inhibitor S-TuD

Precursor miRNA and applications in tumor therapy thereof

Compositions and methods for treating leukemia

CXCR4 BINDING AGENTS FOR TREATMENT OF DISEASES

Highly stable and specific molecular beacons encapsulated in cationic lipoplex nanoparticles and application thereof

MicroRNA-328 anti-sense composition and therapeutic use

METHOD FOR INDIVIDUALIZED CANCER THERAPY

TOOLS AND METHODS USING MIRNA 182, 96 AND/OR 183 FOR TREATING PATHOLOGIES

Method for introducing site-directed RNA mutation, target editing guide RNA used in the method and target RNA-target editing guide RNA complex

HUMAN CANCER MICRO-RNA EXPRESSION PROFILES PREDICTIVE OF CHEMO-RESPONSE

INHIBITORS OF CACNA1A/ALPHA1A SUBUNIT INTERNAL RIBOSOMAL ENTRY SITE (IRES) AND METHODS OF TREATING SPINOCEREBELLAR ATAXIA TYPE 6

Micromirs

NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT

CRISPRs

Amine-containing transfection reagents and methods for making and using same

Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer

Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor

Micro-RNA for the treatment of malignant solid tumors and metastasis

MicroRNA inhibition for the treatment of inflammation and myeloproliferative disorders

Device and method to treat esophageal disorders

Methods of making and using live attenuated viruses

miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

IDENTIFICATION OF EPIGENETIC BIOMARKERS IN THE SALIVA OF CHILDREN WITH AUTISM SPECTRUM DISORDER

Targeting microRNAs for metabolic disorders

Self-assembled ribonucleoprotein nanoparticles

Methods of delivery of transgenes for treating brain diseases

Lipid-derived neutral nanoparticles

Lipid-derived neutral nanoparticles

Micro-RNA family that modulates extracellular matrix genes and uses thereof

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS OF USE THEROF

COMPOSITION AND METHODS FOR REGULATING INHIBITORY INTERACTIONS IN GENETICALLY ENGINEERED CELLS

COMPOSITIONS AND METHODS FOR MODULATING ONCOGENIC MIRNA

Use of an miRNA to reduce proliferation of a cancer cell

Materials and methods for modulation of tendon healing

INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

Chemical modification of short small hairpin RNAs for inhibition of gene expression

GENOME EDITING VECTORS

Compositions and methods for delivery of agents

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions

REGULATOR TARGETING FATTY ACID SYNTHASE AND METHOD OF USING THE SAME FOR IMPROVING MEAT QUALITY

Methods and compositions for the activation of gamma-delta T-cells

Methods and compositions for the activation of gamma-delta T-cells

Method of regulating gene expression

Generation of neural stem cells and motor neurons

Targeting macula densa cells as a new therapeutic approach for kidney disease

Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules

Targeting microRNAs for the treatment of liver cancer

METHODS RELATING TO THE PREVENTION AND TREATMENT OF DRUG RESISTANCE

Continuously expressed therapeutic RNAs for targeted protein binding and methods for their use

Topical Compositions And Methods For Stimulating MIR-146A In Skin Cells

Cell engineering using MICRORNAs

Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability

Methods for treating acute myeloid leukemia and nanoparticle complexes of miR-22 utilized therein

REGULATION OF MIR-33 MICRORNAS IN THE TREATMENT OF CHOLESTEROL-RELATED DISORDERS

MiRNA compositions for the treatment of mature B-cell neoplasms

Segmented micro RNA mimetics

Smooth muscle specific inhibition for anti-restenotic therapy

A METHOD OF REGULATING GENE EXPRESSION

Exosomes and micro-ribonucleic acids for tissue regeneration

AAV treatment of Huntington's disease

Methods to detect motor neuron disease comprising micro-RNAs

RNA nanoparticles and method of use thereof

COMPETITIVE MODULATION OF MICRORNAS

THERAPEUTICS AND METHODS OF TREATING FIBROPROLIFERATIVE DISEASES

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

MIRNA MIMETICS AND THEIR USE IN TREATING SENSORY CONDITIONS

Homologous recombination factors

Plasmonic nanoparticle immunoassay method

Methods to Accelerate Wound Healing in Diabetic Subjects

CITRUS-GREENING (HUANGLONGBING)-INDUCED SMALL RNAS ARE POTENTIAL EARLY DIAGNOSIS MARKERS

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer

Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing

METHODS OF TREATING MOTOR NEURON DISEASES

Assay for telomere length regulators

miRNA modulators of thermogenesis

Compositions and methods for inhibition of nucleic acids function

COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS

Preeclampsia

Gene vector

RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION

Therapeutic miRNAs for treating heart and skeletal muscle diseases

Compositions and methods using capsids resistant to hydrolases

Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers

MicroRNA therapy for pancreatic cancer

siRNA compounds comprising terminal substitutions

Pharmaceutical composition for treating cancer comprising microrna as active ingredient

Extracellular vesicles for agent delivery

Compositions and methods for delivery of agents

Hybrid oligonucleotides and uses thereof

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

Recombinant AAV variants and uses thereof

Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same

Methods and agents to increase therapeutic dystrophin expression in muscle

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

HIV pre-immunization and immunotherapy

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL

Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells

Composition for reducing cellular senescence level including activity inhibitor inhibiting DCUN1D3 activity or expression inhibitor inhibiting expression of DCUN1D3-encoding gene and use thereof

Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor

INHIBITORS OF HEMOPOIETIC CELL KINASE (P-59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION

Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds

Therapeutic compositions for breast cancer containing protein kinase D1 inhibitor

MicroRNAs Sensitize Cancers to Therapy